Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo, and AI/ML methods to...

Are you refining and optimizing your in vivo gene editing delivery strategies for the next generation of gene editors to unlock increased therapeutic efficacy, safety, and cost...